Sep 2026· Applied Biochemistry and Biotechnology· Vol 198, pp. 9020 - 9038· 0 citations· 30 references
Medicine
TL;DR
Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.
The results suggest that the pro-tumorigenic effects of XPR1 in thyroid carcinoma cells, manifested by increased cell growth, motility, invasiveness, and reduced susceptibility to apoptosis, may be partly associated with NF-κB signaling.
J. You, Tong-Xin Zou, Bo-Xiu Wang et al.· Discover medicine· 0 citations
HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.
Shi-Cheng Feng, Min Feng, Zhi-Qiang Lu et al.· Frontiers in Oncology· 0 citations
The functional role of ACOT7 was examined using an integrated approach, combining analysis of clinical datasets with in vitro and in vivo experiments, and MYC-associated regulation and changes in total AKT and p-MDM2 levels suggest a potential connection between ACOT7 and growth-related signaling.
Zhen-Ning Jin, Jia-Yi Peng, Diana Messadi et al.· Cancer & Metabolism· 0 citations
Silencing of TMEM33 markedly suppresses CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo, and significantly reduces subcutaneous tumor growth and pulmonary metastatic burden.
Rui Li, Li Zhao, Nan-Nan Chai et al.· Human Cell· 0 citations